Zsuzsanna Kahán

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial

Javier Cortés, David W. Cescon, Hope S. Rugo et al. · The Lancet · 2020 · 1.8K citations · Full text

Medicine, Oncology, Pharmacology +16

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial

Andrea Wang‐Gillam, Chung‐Pin Li, G. Bodoky et al. · The Lancet · 2015 · 1.2K citations

Medicine, Oncology, Pharmacology +16

Delays in diagnosis and treatment of breast cancer: a multinational analysis

Jacek Jassem, Vahit Özmen, Florin Bacanu et al. · European Journal of Public Health · 2013 · 148 citations · Full text

Medicine, Oncology, Breast Oncology +12

Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin

Attila Nagy, Andrew V. Schally, Gábor Halmos et al. · Proceedings of the National Academy of Sciences · 1998 · 144 citations

Medicine, Medicinal Chemistry, Pharmacology +11

The Risk of Early and Late Lung Sequelae After Conformal Radiotherapy in Breast Cancer Patients

Zsuzsanna Kahán, Melinda Csenki, Zoltán Varga et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 139 citations

Medicine, Oncology, Radiation Oncology +12